Serum GFAP in multiple sclerosis: correlation with disease type and MRI markers of disease severity
出版年份 2020 全文链接
标题
Serum GFAP in multiple sclerosis: correlation with disease type and MRI markers of disease severity
作者
关键词
-
出版物
Scientific Reports
Volume 10, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-07-02
DOI
10.1038/s41598-020-67934-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Glial Activation Markers in CSF and Serum From Patients With Primary Progressive Multiple Sclerosis: Potential of Serum GFAP as Disease Severity Marker?
- (2019) Ahmed Abdelhak et al. Frontiers in Neurology
- Blood neurofilament light chain as a biomarker of MS disease activity and treatment response
- (2019) Jens Kuhle et al. NEUROLOGY
- Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD
- (2019) Mitsuru Watanabe et al. NEUROLOGY
- Association Between Serum Neurofilament Light Chain Levels and Long-term Disease Course Among Patients With Multiple Sclerosis Followed up for 12 Years
- (2019) Ester Cantó et al. JAMA Neurology
- Serum neurofilament light chain levels associations with gray matter pathology: a 5‐year longitudinal study
- (2019) Dejan Jakimovski et al. Annals of Clinical and Translational Neurology
- Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis
- (2018) Christian Barro et al. BRAIN
- Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
- (2018) Alan J Thompson et al. LANCET NEUROLOGY
- Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis
- (2018) Nelly Siller et al. Multiple Sclerosis Journal
- Multiple Sclerosis
- (2018) Daniel S. Reich et al. NEW ENGLAND JOURNAL OF MEDICINE
- Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis
- (2018) Nelly Siller et al. Multiple Sclerosis Journal
- Partial volume-aware assessment of multiple sclerosis lesions
- (2018) Mário João Fartaria et al. NeuroImage-Clinical
- Serum GFAP as a biomarker for disease severity in multiple sclerosis
- (2018) A. Abdelhak et al. Scientific Reports
- Serum glial fibrillary acidic protein correlates with multiple sclerosis disease severity
- (2018) Heidi Högel et al. Multiple Sclerosis Journal
- Science is 1% inspiration and 99% biomarkers
- (2017) Nicolas Dubuisson et al. Multiple Sclerosis Journal
- Science is 1% inspiration and 99% biomarkers
- (2017) Nicolas Dubuisson et al. Multiple Sclerosis Journal
- Glial and neuronal markers in cerebrospinal fluid in different types of multiple sclerosis
- (2016) M.Alba Mañé-Martínez et al. JOURNAL OF NEUROIMMUNOLOGY
- Automated detection of white matter and cortical lesions in early stages of multiple sclerosis
- (2015) Mário João Fartaria et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis
- (2015) M Alba Mañé Martínez et al. Multiple Sclerosis Journal
- Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis
- (2015) M Alba Mañé Martínez et al. Multiple Sclerosis Journal
- Assessing tissue damage in multiple sclerosis: a biomarker approach
- (2014) J. Burman et al. ACTA NEUROLOGICA SCANDINAVICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started